Albireo Pharma

-$0.09 (-0.31%) As of 6:55 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Albireo Pharma and other ETFs, options, and stocks.

About ALBO

Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat.

CEO
Ronald H. W. Cooper
Employees
90
Headquarters
Boston, Massachusetts
Founded
2003

ALBO Key Statistics

Market Cap
638.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
592.55K
High Today
$30.25
Low Today
$28.60
Open Price
$29.57
Volume
147.60K
52 Week High
$49.00
52 Week Low
$22.78

ALBO Earnings

-$2.29
-$1.53
-$0.76
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure